Pharmaceutical Market Research Insights And Findings
Pharmaceutical Research
Survey finds reputation of pharma is improving
March 2016
According to a recent pharmaceutical survey, the sector is enjoying an increase in popularity as a result of efforts to create an approach focussed on patients. The annual survey revealed that approximately 45 per cent of the patient groups who were polled… Read more...
Survey reveals 20 per cent of UK individuals have misused over the counter drugs
February 2016
A recent pharmaceutical survey found that around 20 per cent of Britain’s population have misused over the counter drugs at some point in their life. The misuse was mainly via using the medication longer than advised, taking it in a higher dose or using… Read more...
Survey reveals many have substituted prescriptions for cannabis
January 2016
A recent survey by the Centre for Addictions Research of BC, in Canada, has revealed that many people have replaced prescription medicine for marijuana. The pharmaceutical and alcohol industries – which are hugely powerful influences in Washington –… Read more...
Pharma research finds correlation between antibiotic prescriptions, patient satisfaction
December 2015
According to research by King’s College London, there is a correlation between the amount of prescriptions issued for antibiotics and patient satisfaction scores, with the GPs prescribing less antibiotics receiving lower patient satisfaction scores.… Read more...
More than half of Northern Ireland is taking prescription drugs, survey finds
November 2015
A recent survey by the Department of Health in Northern Ireland has discovered that more than half of people in Northern Ireland are taking prescription drugs. The annually published survey – entitled ‘the Health Survey Northern Ireland’–… Read more...
Survey finds health workers support transparency on payments from pharma companies
November 2015
A new survey commissioned by the Association of the British Pharmaceutical Industry has discovered that most healthcare workers in the United Kingdom back greater transparency on the payments received by pharmaceutical companies. However, a proportion think… Read more...
